| [1] |
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5): 843-854.
|
| [2] |
Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[J]. Nature, 2000, 403(6772): 901-906.
|
| [3] |
Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs[J]. Science, 2001, 294(5543): 853-858.
|
| [4] |
Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell, 2009, 136(2): 215-233.
|
| [5] |
Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24): 15524-15529.
|
| [6] |
Croce CM. Causes and consequences of microRNA dysregulation in cancer[J]. Nat Rev Genet, 2009, 10(10): 704-714.
|
| [7] |
Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis[J]. Br J Cancer, 2006, 94(6): 776-780.
|
| [8] |
Baranwal S, Alahari SK. miRNA control of tumor cell invasion and metastasis[J]. Int J Cancer, 2010, 126(6): 1283-1290.
|
| [9] |
Heinrich EM, Dimmeler S. MicroRNAs and stem cells control of pluripotency, reprogramming, and lineage commitment[J]. Circ Res, 2012, 110(7): 1014-1022.
|
| [10] |
Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin[J]. Nat Biotechnol, 2008, 26(4): 462-469.
|
| [11] |
Ma J, Dong C, Ji C. MicroRNA and drug resistance[J]. Cancer Gene Ther, 2010, 17(8): 523-531.
|
| [12] |
Martina Redova, Jiri Sana, Ondrej Slaby. Circulating miRNAs as new blood-based biomarkers for solid cancers[J]. Future Oncol, 2013, 9(3): 387-402.
|
| [13] |
Bader AG, Brown D, Stoudemire J, et al. Developing therapeutic microRNAs for cancer[J]. Gene Ther, 2011, 18(12): 1121-1126.
|
| [14] |
Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase Ⅱ[J]. EMBO J, 2004, 23(20): 4051-4060.
|
| [15] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 281-297.
|
| [16] |
Sun Y, Chen C, Zhang P, et al. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway[J]. Sci Rep, 2014, 4: 6527.
|
| [17] |
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci U S A, 2004, 101(9): 2999-3004.
|
| [18] |
Merritt WM, Lin YG, Han LY, et al. Dicer, Drosha, and outcomes in patients with ovarian cancer[J]. N Engl J Med, 2008, 359(25): 2641-2650.
|
| [19] |
Fabbri M, Calore F, Paone A, et al. Epigenetic regulation of miRNAs in cancer[J]. Adv Exp Med Biol, 2013, 754: 137-148.
|
| [20] |
Saito Y, Liang G, Egger G, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells[J]. Cancer Cell, 2006, 9(6): 435-443.
|
| [21] |
Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B[J]. Proc Natl Acad Sci U S A, 2007, 104(40): 15805-15810.
|
| [22] |
O'Donnell KA, Wentzel EA, Zeller KI, et al. c-Myc-regulated microRNAs modulate E2F1 expression[J]. Nature, 2005, 435(7043): 839-843.
|
| [23] |
Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth[J]. Cancer Res, 2007, 67(18): 8433-8438.
|
| [24] |
Acunzo M, Romano G, Palmieri D, et al. Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2[J]. Proc Natl Acad Sci U S A, 2013, 110(21): 8573-8578.
|
| [25] |
Liang Z, Li Y, Huang K, et al. Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN[J]. Pharm Res, 2011, 28(12): 3091-3100.
|
| [26] |
Shi GH, Ye DW, Yao XD, et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells[J]. Acta Pharmacol Sin, 2010, 31(7): 867-873.
|
| [27] |
Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 down regulation[J]. Cancer Cell, 2009, 16(6): 498-509.
|
| [28] |
Acunzo M, Visone R, Romano G, et al. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222[J]. Oncogene, 2012, 31(5): 634-642.
|
| [29] |
Bao L, Hazari S, Mehra S, et al. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298[J]. Am J Pathol, 2012, 180(6): 2490-2503.
|
| [30] |
Zhu H, Wu H, Liu X, et al. Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells[J]. Biochem Pharmacol, 2008, 76(5): 582-588.
|
| [31] |
Zhu X, Li H, Long L, et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A[J]. Acta Biochim Biophys Sin, 2012, 44(6): 519-526.
|
| [32] |
Romano G, Acunzo M, Garofalo M, et al. MiR-494 is regulated by ERK1/2 and modulates TRAIL induced apoptosis in non-small-cell lung cancer through BIM down-regulation[J]. Proc Natl Acad Sci U S A, 2012, 109(41): 16570-16575.
|
| [33] |
Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci U S A, 2006, 103(7): 2257-2261.
|
| [34] |
Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks[J]. Nat Cell Biol, 2013, 15(6): 546-554.
|
| [35] |
Png KJ, Halberg N, Yoshida M, et al. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells[J]. Nature, 2011, 481(7380): 190-194.
|
| [36] |
Drusco A, Nuovo GJ, Zanesi N, et al. MicroRNA profiles discriminate among colon cancer metastasis[J]. PLoS One, 2014, 9(6): e96670.
|
| [37] |
Scholl V, Hassan R, Zalcberg IR. miRNA-451: a putative predictor marker of Imatinib therapy response in chronic myeloid leukemia[J]. Leuk Res, 2012, 36(1): 119-121.
|
| [38] |
Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease？[J] Circ Res, 2012, 110(3): 483-495.
|
| [39] |
Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel non-invasive biomarkers for non-small cell lung cancer diagnosis[J]. Int J Cancer, 2012, 130(7): 1620-1628.
|
| [40] |
Lagana A, Acunzo M, Romano G, et al. miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs[J]. Nucleic Acids Res, 2014, 42(9): 5416-5425.
|
| [41] |
Choi KY, Silvestre OF, Huang XL, et al. A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo[J]. Nat Protoc, 2014, 9(8): 1900-1915.
|